Navigation Links
Neurobiological Technologies Reports Third Quarter Fiscal 2009 Financial Results
Date:5/8/2009

million, or $0.76 per share, for the nine months ended March 31, 2008.

Cash, cash equivalents and investments were $28.8 million at March 31, 2009. The cash and total investments balance included cash, cash equivalents and short-term investments of $21.6 million and long-term auction-rate securities carried at an estimated value of $7.2 million and classified as long-term investments. Total liabilities, excluding deferred revenue of $14.7 million and a warrant liability of $0.2 million, were $6.4 million at March 31, 2009.

"During the third quarter of fiscal 2009, we wound-down most of our operations and significantly reduced expenses. We also initiated a process to identify and evaluate alternatives for the Company's future. Our board's stated mandate in looking at these strategic alternatives is to maximize the value of our cash and other assets for the benefit of all our shareholders, and to proceed expeditiously in the process," stated William Fletcher, acting Chief Executive Officer.

Assuming accrued costs associated with the Viprinex program are fully paid off by June 30, 2009 as currently estimated, the Company expects to end its fiscal year with approximately $23 million in cash, short-term and long-term investments.

-Tables to follow -

About Neurobiological Technologies, Inc.

Neurobiological Technologies, Inc. is a biopharmaceutical company historically focused on developing investigational drugs for central nervous system conditions. The company recently terminated development of its most advanced product candidate, Viprinex(TM) (ancrod), which was studied in Phase 3 clinical trials as a potential new drug to treat acute ischemic stroke. NTI has more recently chosen not to extend its early-stage research programs for Huntington's and Alzheimer's diseases. NTI has rights to receive payments from an approved drug for Alzheimer's disease and an invest
'/>"/>

SOURCE Neurobiological Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Neurobiological Technologies Announces Appointment of William A. Fletcher as Acting CEO
2. Neurobiological Technologies Reports Second Quarter Financial Results
3. Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
4. Neurobiological Technologies Announces Compliance With Nasdaq Listing Standards
5. Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
6. Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ
7. Neurobiological Technologies Reports Going Concern Qualification
8. Steven H. Kane Appointed as President and Chief Executive Officer of Patient Safety Technologies, Inc.
9. Global Med Technologies(R), Inc. to Report First Quarter Financial Results on Friday, May 15, 2009
10. EF Johnson Technologies, Inc. Announces First Quarter 2009 Financial Results
11. Greenway Medical Technologies PrimeSuite Solution Provides OB/GYN Physicians With Instant Access to Labor and Delivery Information at Point-of-Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 2015 ZH Healthcare ... announced today that Bill Lane, joins ZH’s Advisory ... of BlueEHS,a first of its kind, Freemium SaaS, ... Electronic Health Records (EHR) with an integrated practice ... comprehensive patient portal, and more. Combined with its ...
(Date:5/22/2015)... May 22, 2015 Gateway Building Concepts ... renovations. The services the company specialize in include decks, ... basements, pool houses and much more. , The ... the owner of the company. It includes two geometrical ... design was thought out to be used with many ...
(Date:5/22/2015)... 2015 A Phase 3 French ... Society of Clinical Oncology (ASCO)’s annual meeting at ... for those patients who received bevacizumab in addition ... Bevacizumab (Avastin® Genentech, Inc.) is an antibody that ... already routinely used to treat many other cancers, ...
(Date:5/22/2015)... 22, 2015 Ticket Down is a reputable ... Rangers NHL Eastern Conference Finals Tickets . All seating ... otherwise in the ticket listing. , For the first ... the top of the Eastern Conference. One of the original ... of ups and downs over the years, but the excitement ...
(Date:5/22/2015)... May 22, 2015 In April 2006, ... the past 9 years they have concentrated their focus ... States and Canada. Because of this growth and their ... corporate offices in Denver, Colorado, Cleveland, Ohio, Houston, Texas ... in opening new dental offices, dental start ups, orthodontic ...
Breaking Medicine News(10 mins):Health News:ZH Healthcare Adds Bill Lane to Advisory Board 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 3
... medulloblastoma in children , SATURDAY, June 5 (HealthDay News) ... treatment for medulloblastoma -- the most common malignant brain ... to treat drug-resistant forms of the disease. , "Less ... Dr. Amar Gajjar, lead author of the study, which ...
... chemotherapy, new drug prolonged lives of some with advanced ... report they prolonged survival for some patients with advanced ... is currently only about six months. , One ... tumors in the majority of lung cancer patients with ...
... Great HealthWorks, makers and distributors ... the top of Mt. Everest. , ... June 5, 2010 -- The Great HealthWorks Team wishes to congratulate Jordan Romero for achieving history ... Jordan saw a mural in the hallway at school of Mt. McKinley that caught his attention. ...
... halted early because of supplement,s poor performance , SATURDAY, ... supplement selenium doesn,t reduce the likelihood of lung cancer ... Daniel D. Karp, a professor in the department of ... Texas M.D. Anderson Cancer Center, is scheduled to present ...
... ... and Faces iMake, among Father’s Day 2010 GreatDad Recommends Award and Mr. Dad Seal of ... San Francisco, ... activities this year are in for a real treat. Presented by Mr. Dad and GreatDad.com, ...
... ... drug rehabs and prisons , ... (PRWEB) June 5, 2010 -- President Narconon International, Clark Carr, just finished ... withdrawal and relapse prevention technology to Mexico. Accompanied by U.S. and Mexican volunteers, Carr ...
Cached Medicine News:Health News:Targeted Therapy Shows Promise Against Deadly Brain Cancer 2Health News:Researchers Report Treatment Headway Against Lung Cancer 2Health News:Researchers Report Treatment Headway Against Lung Cancer 3Health News:Great Healthworks, Makers Omega XL, Congratulates Jordan Romero as The Youngest Person to Ever Reach The Top of Mt. Everest 2Health News:Don't Count on Selenium to Prevent Lung Cancer Recurrence 2Health News:Mr. Dad and GreatDad.com Salute Fathers and Families with This Spring's ‘Seal of Approval' Picks 2Health News:Mr. Dad and GreatDad.com Salute Fathers and Families with This Spring's ‘Seal of Approval' Picks 3Health News:Mr. Dad and GreatDad.com Salute Fathers and Families with This Spring's ‘Seal of Approval' Picks 4Health News:Narconon Campaigns to Help Mexico Reduce Drug-related Violence in Sonora and Michoacan 2
(Date:5/21/2015)... , May 21, 2015  (MUSE Booth ... Electronic Health Record (EHR) is invaluable in any ... EHRs are now a requirement and mainstream in ... continuously into the EHR is gaining traction in ... William Holmes, RN, Site Project Manager & Clinical ...
(Date:5/21/2015)... In praising today,s unanimous passage of ... House Energy and Commerce Committee, the Senior Care ... the unique challenges facing long-term care (LTC) pharmacy ... exempting Part D beneficiaries in skilled nursing facilities ... "lock-in" provision. The SCPC has made the case ...
(Date:5/21/2015)... and SEATTLE , May 21, ... the development of robotics, sensors and medical devices, announced ... the company,s Chief Financial Officer and head of Corporate ... in corporate development, business development and finance roles, including ... and Pendrell Corporation.  Mr. Woo will be located in ...
Breaking Medicine Technology:Hospital Streamlines ICU Efficiency with Timely Data Integration 2Hospital Streamlines ICU Efficiency with Timely Data Integration 3SCPC Applauds Unanimous House Panel Passage of 21st Century Cures Bill Recognizing Unique Challenges Facing Long Term Care (LTC) Pharmacy Patients, Providers 2Sarcos Corp. Announces Preston Woo as CFO and Head of Corporate Development 2
... (Pink Sheets: SNDY ) is pleased to announce ... surgical instruments in order to better align its product offerings ... has focused its R & D efforts into the design ... to accommodate the continual advances in Laparoscopic surgical procedures including ...
... Ala., March 24, 2011 Qualitest Pharmaceuticals today announced that ... tablets (generic Demadex®) in 5 mg, 10 mg, ... for the treatment of edema associated with congestive heart failure, ... hypertension alone or in combination with other antihypertensive agents. ...
Cached Medicine Technology:Solos Endoscopy, Inc. Strengthens Current Line of Laparoscopic Instruments 2Qualitest Receives FDA Approval for Toresmide Tablets (Generic Demadex®) 5 mg, 10 mg, 20 mg, 100 mg, for the Treatment of Edema Associated with Congestive Heart Failure, Renal Disease, or Hepatic Disease 2Qualitest Receives FDA Approval for Toresmide Tablets (Generic Demadex®) 5 mg, 10 mg, 20 mg, 100 mg, for the Treatment of Edema Associated with Congestive Heart Failure, Renal Disease, or Hepatic Disease 3
BD Vacutainer® Plus Plastic Serum Tubes have spray-coated silica and are used for serum determinations in chemistry, serology, and immunohematology....
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
BD Vacutainer® Heparin Tubes are spray-coated with either lithium heparin or sodium heparin and are used for plasma determinations in chemistry....
... contain a buffered sodium citrate ... a citrate concentration of 0.109 ... (3.8%). The mixing ratio is ... 9 parts blood. In addition ...
Medicine Products: